Target effector role of vascular endothelium in the inflammatory response: insights from the clinical trial of anti-TNF alpha antibody in rheumatoid arthritis.
Author:
Open Access
- 1 October 1997
- journal article
- review article
- Published by BMJ in Molecular Pathology
- Vol. 50 (5) , 225-233
Abstract
Rheumatoid arthritis (RA) is characterised by chronic joint inflammation and infiltration by cells from the blood, especially activated T cells and macrophages, together with formation of new blood vessels. The overgrowth of the synovial lesion results eventually in destruction of cartilage and bone. Cytokines play a major role in RA, both in systemic inflammatory processes, such as induction of acute phase protein synthesis, and in the stimulation of new blood vessel development and recruitment of leucocytes to developing lesions. The focus for the interplay of many cytokines is the endothelium, the lining layer of the vasculature. This is the primary target for circulating mediators, and it controls the traffic of cells and molecules from the bloodstream into underlying tissues. Targeting the action of individual cytokines--for example, using antibody against tumour necrosis factor alpha (TNF alpha), has been shown to be very effective in the treatment of RA. Blockade of TNF alpha activity results in deactivation of the endothelium, manifested as reduced expression of adhesion molecules and chemoattractant cytokines, leading to diminished trafficking of inflammatory cells to synovial joints. In addition anti-TNF alpha decreases circulating levels of the potent angiogenic cytokine VEGF, suggesting that new blood vessel formation, and hence the supply of nutrients to the growing synovial lesion, is also affected. These observations lend further support to the hypothesis that interruption of a component of the cytokine network in RA may modulate disease progression, and point the way towards the development of new therapeutic strategies for the treatment of chronic inflammatory disease states.Keywords
This publication has 85 references indexed in Scilit:
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic AgentJournal of Biological Chemistry, 1996
- Soluble Intercellular Adhesion Molecule‐1 (ICAM‐1) Antigen in Patients with Rheumatoid ArthritisScandinavian Journal of Immunology, 1993
- A Major Portion of Polymorphonuclear Leukocyte and T Lymphocyte Migration to Arthritic Joints in the Rat Is via LFA-1/MAC-1-Independent MechanismsClinical Immunology and Immunopathology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Adhesion molecule expression in human synovial tissueArthritis & Rheumatism, 1993
- Proteoglycans on endothelial cells present adhesion-inducing cytokines to leukocytesImmunology Today, 1993
- Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cellsBiochemical and Biophysical Research Communications, 1992
- Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage pannus junctionClinical and Experimental Immunology, 1991
- Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1Biochemical and Biophysical Research Communications, 1991